Search clinical trials for: Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes

Total 352 results

NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Neoplasm Metastasis

Russian Federation
NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Personalized Immunotherapy of Glioblastoma

Glioblastoma

Russian Federation
NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Neoplasm Metastasis

Russian Federation
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Immunex Corporation

Withdrawn

Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins All Children's Hospital

Withdrawn

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Neoplasms, Nerve Tissue | Neuroblastoma
Jan Walewski

Completed

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

Lymphoma | Multiple Myeloma and Plasma Cell Neoplasm

Poland
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...

Unknown

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

Germany
Boston Medical Center

Terminated

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Leukemia

United States
Roswell Park Cancer Institute

Completed

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Sarcoma | Neuroblastoma | Wilm's Tumor

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Lymphoma

China
Northwestern University

Terminated

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Sarcoidosis

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Prostate Cancer

United States
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

β-thalassemia

China
Shenzhen Hemogen

Recruiting

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

β-thalassemia

China
Oslo University Hospital

Completed

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Glioblastoma | Brain Tumor
Gary Archer Ph.D.
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (ATTAC)

Malignant Neoplasms of Brain

United States
Maria Sklodowska-Curie National Research Institute...

Unknown

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Melanoma (Skin)

Poland
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

α-thalassemia

China
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Suspended

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Thalassemia Major

China
Bioray Laboratories
Xiangya Hospital of Central South University; The 923rd Hospital of Joint Logistics...

Completed

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

β Thalassemia Major

China
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Lung Cancer

United States
Centro de Hematología y Medicina Interna

Enrolling by invitation

Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells

Multiple Sclerosis
European Society for Blood and Marrow Transplantation
The Broad Foundation

Terminated

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

Crohn Disease

United Kingdom, Italy, Switzerland, Belgium, Canada, France, Spain
Edward Hirschowitz
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
N.N. Petrov National Medical Research Center of...

Unknown

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma (ADCVCTAST)

Sarcoma | Neoplasms, Connective and Soft Tissue

Russian Federation
Mayo Clinic
National Cancer Institute (NCI)

Completed

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

Lymphoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphoid System Neoplasm | Cytomegaloviral Infection

United States
University of Florida
Oligo Nation, Inc

Not yet recruiting

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients (ADAGiO)

Recurrent Oligodendroglioma | Progressive Oligodendroglioma

United States
Bioray Laboratories
Nanfang Hospital, Southern Medical University

Not yet recruiting

Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease

Sickle Cell Disease
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Clinical Study of BRL-101 in Severe SCD

Sickle Cell Disease

China
Joshua Sasine, MD, PhD

Recruiting

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Multiple Myeloma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Large B-cell Lymphoma

United States
Institute of Hematology & Blood Diseases Hospital
Cellular Biomedicine Group Ltd.

Recruiting

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Multiple Myeloma

China
University of Pittsburgh

Completed

Immunization Against Tumor Cells in Sezary Syndrome

Sezary Syndrome | Cutaneous T-cell Lymphoma

United States
Radboud University Medical Center
Dutch Cancer Society

Completed

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Melanoma Stage III or IV

Netherlands
Lisata Therapeutics, Inc.

Terminated

Vaccine Therapy in Treating Patients With Kidney Cancer

Kidney Cancer

United States
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer (AAV-DC-CTL)

Stage IV Gastric Cancer

China
Radboud University Medical Center

Completed

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Melanoma

Netherlands
Bioray Laboratories
Chinese Academy of Medical Sciences

Not yet recruiting

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

Sickle Cell Disease
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin Lymphoma

United States
Abu Dhabi Stem Cells Center

Completed

Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers. (SANTANA)

Healthy

United Arab Emirates
Bioray Laboratories
Xiangya Hospital of Central South University; First Affiliated Hospital of... and other collaborators

Enrolling by invitation

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

Beta-Thalassemia

China
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Sarcoma | Neuroectodermal Tumors, Primitive, Peripheral | Neuroblastoma | Rhabdomyosarcoma-Embryonal | Rhabdomyosarcoma- Alveolar

United States
Jonsson Comprehensive Cancer Center

Completed

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

United States
Leo W. Jenkins Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
Hoag Memorial Hospital Presbyterian

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

Melanoma (Skin)

United States
Rockefeller University
Memorial Sloan Kettering Cancer Center

Completed

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

Prostate Cancer

United States

Search clinical trials for: Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations